OphthalmologyNews.net

Ophthalmology Xagena

Long-term daily multivitamin supplement use may lower cataract risk in men, according to a study of nearly 15,000 male physicians published in Ophthalmology, the journal of the American Academy of Oph ...


The aim of the GEFAL trial was to evaluate the relative efficacy and safety profile of Bevacizumab ( Avastin ) versus Ranibizumab ( Lucentis ) intravitreal injections for the treatment of neovascular ...


Bayer HealthCare has announced that Eylea ( Aflibercept solution for injection ) has been approved by the European Commission ( EC ) for the treatment of visual impairment due to macular edema seconda ...


The EMA’s Committee for Medicinal Products for Human Use ( CHMP ) has recommended marketing authorisation for Jetrea, a medicinal product indicated for the treatment of adults with vitreomacular tract ...


Results for VEGF Trap-Eye ( Aflibercept ophthalmic solution ) from the Phase 3 MYRROR study in myopic choroidal neovascularization ( mCNV ) were presented. Patients receiving VEGF Trap-Eye at a dose o ...


The experimental drug Selumetinib is the first targeted therapy to demonstrate significant clinical benefit for patients with metastatic uveal melanoma.The findings are potentially practice-changing f ...


Regeneron has announced that detailed one-year results from the VIEW 1 and VIEW 2 phase 3 studies of Aflibercept ( Eylea ) injection, published in the journal Ophthalmology. Eylea, for the treatmen ...


Taking oral antiviral medications following infection with the herpes simplex virus may be associated with a reduced risk of recurring eye-related manifestations of the disease.Herpes simplex virus ( ...


People whose diet includes a lot of red meat are more likely to develop the early stages of an eye condition known as age-related macular degeneration ( AMD ), which is the leading cause of vision los ...


A small group of patients with severe Graves' eye disease experienced rapid improvement of their symptoms — and improved vision — following treatment with the drug Rituximab MabThera, Rituxan ). Infla ...


Researchers from Boston University School of Medicine ( BUSM ) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between ...


Patients with diabetes who take the medication Rosiglitazone ( Avandia ) may be less likely to develop the eye disease proliferative diabetic retinopathy or to experience reductions in visual acuity.P ...


A low-vision therapy program that includes a home visit, counseling, assistive devices such as magnifiers and assignments to practice using them appears to significantly improve vision in veterans wit ...


Corneal grafts obtained from donors dying in the hospital or with cancer may be associated with an increased risk of infection for the recipient. Infection is an uncommon but serious complication o ...


Research conducted by Reza Dana, at the Massachusetts Eye and Ear Infirmary ( MEEI ) Cornea Service, and colleagues at the Schepens Eye Research Institute, have found for the first time that topical d ...


Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum ...


Current and past smokers appear to have a higher risk of developing late age-related macular degeneration than those who have never smoked. Age-related macular degeneration ( AMD ) is the leading c ...


The interplay between genetic predisposition and exposure to modifiable risk factors can multiply the risk for age-related macular degeneration. Age-related macular degeneration ( AMD ) can cause b ...


The statins are associated with a lower incidence of nuclear cataract, the most common type of age-related cataract. Statins are widely used to decrease serum cholesterol for cardiovascular disease ...


A study, led by researchers at Columbia University Medical Center and published in Nature Genetics, pinpoints the role that two genes, Factor H and Factor B, play in the development of nearly three ou ...



2000-2014© XAGENA srl - P.IVA: 04454930969 - REA: 1748680 - Tutti i diritti riservati